Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Androgen levels do not determine the type of PCOS symptoms in young females.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Beard hair follicles convert testosterone to 5α-dihydrotestosterone most intensively.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Testosterone therapy in transgender men can cause acne.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Spironolactone is effective for idiopathic hirsutism but has limited effects on other PCOS symptoms.

Aromatase inhibitors cause male pattern hair loss in women.